Literature DB >> 16401517

Quantitating isotopic molecular labels with accelerator mass spectrometry.

John S Vogel1, Adam H Love.   

Abstract

Accelerator mass spectrometry (AMS) traces isotopically labeled biochemicals and provides significant new directions for understanding molecular kinetics and dynamics in biological systems. AMS traces low-abundance radioisotopes for high specificity but detects them with MS for high sensitivity. AMS reduces radiation exposure doses to levels safe for use in human volunteers of all ages. Total radiation exposures are equivalent to those obtained in very short airplane flights, a commonly accepted radiation risk. Waste products seldom reach the Nuclear Regulatory Commission (NRC) definition of radioactive waste material for (14)C and (3)H. Attomoles of labeled compounds are quantified in milligram-sized samples, such as 20 microl of blood. AMS is available from several facilities that offer services and new spectrometers that are affordable. Detailed examples of designing AMS studies are provided, and the methods of analyzing AMS data are outlined.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16401517     DOI: 10.1016/S0076-6879(05)02013-6

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  27 in total

Review 1.  Accelerator mass spectrometry-enabled studies: current status and future prospects.

Authors:  Ali Arjomand
Journal:  Bioanalysis       Date:  2010-03       Impact factor: 2.681

2.  Bioaccumulation of Multiwall Carbon Nanotubes in Tetrahymena thermophila by Direct Feeding or Trophic Transfer.

Authors:  Monika Mortimer; Elijah J Petersen; Bruce A Buchholz; Eduardo Orias; Patricia A Holden
Journal:  Environ Sci Technol       Date:  2016-07-26       Impact factor: 9.028

Review 3.  Quantifying exploratory low dose compounds in humans with AMS.

Authors:  Stephen R Dueker; Le T Vuong; Peter N Lohstroh; Jason A Giacomo; John S Vogel
Journal:  Adv Drug Deliv Rev       Date:  2010-10-31       Impact factor: 15.470

Review 4.  Pharmacokinetic studies in infants using minimal-risk study designs.

Authors:  Julie Autmizguine; Daniel K Benjamin; P Brian Smith; Mario Sampson; Philippe Ovetchkine; Michael Cohen-Wolkowiez; Kevin M Watt
Journal:  Curr Clin Pharmacol       Date:  2014

5.  Carbon isotopes profiles of human whole blood, plasma, red blood cells, urine and feces for biological/biomedical 14C-accelerator mass spectrometry applications.

Authors:  Seung-Hyun Kim; Jennifer C Chuang; Peter B Kelly; Andrew J Clifford
Journal:  Anal Chem       Date:  2011-03-31       Impact factor: 6.986

6.  Metabolism of the antibacterial triclocarban by human epidermal keratinocytes to yield protein adducts.

Authors:  Nils Helge Schebb; Bruce A Buchholz; Bruce D Hammock; Robert H Rice
Journal:  J Biochem Mol Toxicol       Date:  2012-06       Impact factor: 3.642

Review 7.  Cerebral aneurysms: formation, progression, and developmental chronology.

Authors:  Nima Etminan; Bruce A Buchholz; Rita Dreier; Peter Bruckner; James C Torner; Hans-Jakob Steiger; Daniel Hänggi; R Loch Macdonald
Journal:  Transl Stroke Res       Date:  2013-10-30       Impact factor: 6.829

8.  Quality of graphite target for biological/biomedical/environmental applications of 14C-accelerator mass spectrometry.

Authors:  Seung-Hyun Kim; Peter B Kelly; Volkan Ortalan; Nigel D Browning; Andrew J Clifford
Journal:  Anal Chem       Date:  2010-03-15       Impact factor: 6.986

9.  Calculating radiation exposures during use of (14)C-labeled nutrients, food components, and biopharmaceuticals to quantify metabolic behavior in humans.

Authors:  Seung-Hyun Kim; Peter B Kelly; Andrew J Clifford
Journal:  J Agric Food Chem       Date:  2010-04-28       Impact factor: 5.279

10.  Biological/biomedical accelerator mass spectrometry targets. 1. optimizing the CO2 reduction step using zinc dust.

Authors:  Seung-Hyun Kim; Peter B Kelly; Andrew J Clifford
Journal:  Anal Chem       Date:  2008-09-12       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.